News & Analysis on Clinical Trial Services & Contract Research And Development
UK and Swedish researchers have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of biopharmaceutical products, making the process both safer and less costly.
Canada’s Bioxel Pharma believes that the six new generic docetaxel supply deals it has signed, represents a real leap forward in its business plan
in-PharmaTechnologist.com's periodic round-up of developments and deals in the pharmaceutical manufacturing space, includes news on 3M and Ligacon, Dishman, Stiefel and Barrier and Forbes.